Reduction of cardiovascular morbidity and mortality in Type 2 diabetes. A rational approach to hypoglycemic therapy

2004 ◽  
Vol 27 (5) ◽  
pp. 485-495 ◽  
Author(s):  
P. Spallarossa ◽  
A. Barsotti ◽  
R. Cordera ◽  
G. Ghigliotti ◽  
D. Maggi ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Cardiovascular Morbidity ◽  
Morbidity And Mortality ◽  
Rational Approach ◽  
Cardiovascular Morbidity And Mortality ◽  
Hypoglycemic Therapy

Prognostic value of ratio of transmitral early filling velocity to early diastolic strain rate in patients with Type 2 diabetes

2019 ◽  
Vol 20 (10) ◽  
pp. 1171-1178
Author(s):  
Mats Christian Højbjerg Lassen ◽  
Magnus T Jensen ◽  
Tor Biering-Sørensen ◽  
Rasmus Møgelvang ◽  
Thomas Fritz-Hansen ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Strain Rate ◽  
Prognostic Value ◽  
Cardiovascular Morbidity ◽  
Morbidity And Mortality ◽  
Prognostic Information ◽  
Cardiovascular Morbidity And Mortality ◽  
Unit Increase ◽  
Incremental Prognostic Information

Abstract Aims The ratio of early mitral inflow velocity to global diastolic strain rate (E/e′sr) has recently emerged as a novel measure of left ventricular filling pressure. E/e′sr has in previous studies demonstrated to have good prognostic value in various patient populations. The aim of this study is to investigate the prognostic value of E/e′sr in a large cohort of patients with Type 2 diabetes in relation to cardiovascular morbidity and mortality. Methods and results In this prospective study, 848 Type 2 diabetic patients (mean age 63.6 ± 10.3 years, 64.7% male) underwent comprehensive echocardiographic examination including 2D speckle tracking in which E/e′sr along with novel and conventional echocardiographic variables were obtained. During follow-up (median: 4.8 years, interquartile range: 4.0–5.3), 122 (14.1%) met the composite outcome of cardiovascular disease, hospitalization, and mortality. Both E/e′sr and E/e′ were significantly associated with the outcome [E/e′sr: hazard ratio (HR) 1.07, 95% confidence interval (CI): 1.05–1.10; P < 0.001, per 0.10 m increase] and (E/e′: HR 1.07, 95% CI: 1.05–1.10; P = 0.001, per 1 unit increase). E/e′sr remained an independent predictor after multivariable adjustment for demographical, clinical, and echocardiographic parameters (HR 1.06, 95% CI: 1.01–1.12; P = 0.032, per 10 cm increase). The same was true for E/e′ (HR 1.09, 95% CI: 1.04–1.14; P < 0.001, per 1 unit increase). Additionally, E/e′sr provided incremental prognostic information beyond the UK ‘Prospective Diabetes Study risk engine’ 0.72 (0.68–0.77) vs. 0.74 (0.70–79), P = 0.040. Conclusion In patients with Type 2 diabetes, E/e′sr provides independent and incremental prognostic information regarding cardiovascular morbidity and mortality.

Sign in / Sign up

Export Citation Format

Share Document